Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | MFCD00946455 | 100.0% | 495.59 g·mol⁻¹ | C16H18Br2ClN3O3 | 10 MG
SDP

Catalog No. 5000295702
Encompass_Preferred

Halofuginone hydrobromide is a febrifugine derivative and a competitive prolyl-tRNA synthetase inhibitor used as a research standard for studies of collagen synthesis, TGF-β signaling, fibrosis, cancer biology, and anti-parasitic activity.

  • Competitive prolyl-tRNA synthetase inhibitor with reported Ki ≈ 18.3 nM.
  • Inhibits type-I collagen synthesis, useful for fibrosis and TGF-β studies.
  • High reported purity (99.99%), suitable as a reference standard.
  • Characterized molecular weight (495.59 g·mol⁻¹) and CAS number (64924-67-0).
  • Available in small mg quantities for in vitro and pharmacological assays.

Catalog No. 50-002-95702 Supplier Medchemexpress LLC Supplier No. HYN1584AR10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Halofuginone hydrobromide is a febrifugine derivative and a competitive prolyl-tRNA synthetase inhibitor used as a research standard for studies of collagen synthesis, TGF-β signaling, fibrosis, cancer biology, and anti-parasitic activity.

  • Competitive prolyl-tRNA synthetase inhibitor with reported Ki ≈ 18.3 nM.
  • Inhibits type-I collagen synthesis, useful for fibrosis and TGF-β studies.
  • High reported purity (99.99%), suitable as a reference standard.
  • Characterized molecular weight (495.59 g·mol⁻¹) and CAS number (64924-67-0).
  • Available in small mg quantities for in vitro and pharmacological assays.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.